All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAART-LX349 | Anti-Gliadin (1002-1E03) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 1002-1E03 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX350 | Anti-Gliadin (GL 1 ) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | GL 1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX351 | Anti-Gliadin (VHH3) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | VHH3 | alpaca | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX352 | Anti-Gliadin (VHH26) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | VHH26 | alpaca | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX353 | Anti-Gliadin (X8LX144) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | X8LX144 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX354 | Anti-Gliadin (8D12) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 8D12 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX355 | Anti-Gliadin (X8LX145) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | X8LX145 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX356 | Anti-Gliadin (9D12) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 9D12 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX357 | Anti-Gliadin (X8LX143) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | X8LX143 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX358 | Anti-Gliadin (1002-1E03) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 1002-1E03 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX359 | Anti-Gliadin (GL 1 ) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | GL 1 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX360 | Anti-Gliadin (VHH3) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | VHH3 | alpaca | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX361 | Anti-Gliadin (VHH26) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | VHH26 | alpaca | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX362 | Anti-Gliadin (X8LX144) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | X8LX144 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX363 | Anti-Gliadin (8D12) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 8D12 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX364 | Anti-Gliadin (X8LX145) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | X8LX145 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX365 | Anti-Gliadin (9D12) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 9D12 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX366 | Anti-Gliadin (X8LX143) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | X8LX143 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION